Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001877272 | SCV002132820 | uncertain significance | TP63-Related Spectrum Disorders | 2023-06-06 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals affected with TP63-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.009%). This variant, c.1834_1836del, results in the deletion of 1 amino acid(s) of the TP63 protein (p.Ser612del), but otherwise preserves the integrity of the reading frame. |
Fulgent Genetics, |
RCV002482573 | SCV002792985 | uncertain significance | ADULT syndrome; Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome; Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3; Limb-mammary syndrome; Rapp-Hodgkin syndrome; Split hand-foot malformation 4; Orofacial cleft 8 | 2021-07-28 | criteria provided, single submitter | clinical testing |